Introduction Adrenal myelolipoma is an invariably benign neoplasm of the adrenal gland
that is the second most common primary adrenal incidentaloma following adrenocortical …

Adrenal incidentalomas are adrenal masses detected on imaging performed for reasons
other than suspected adrenal disease. In most cases, adrenal incidentalomas are …

Almost one decade ago, etoposide, doxorubicin, cisplatin and mitotane (EDP-M) has been
established as first-line systemic therapy of metastatic adrenocortical carcinoma (ACC) …

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Neuroendocrine
and Adrenal Gland Tumors focus on the diagnosis, treatment, and management of patients …

We describe a comprehensive genomic characterization of adrenocortical carcinoma (ACC).
Using this dataset, we expand the catalogue of known ACC driver genes to include …

By definition, an adrenal incidentaloma is an asymptomatic adrenal mass detected on
imaging not performed for suspected adrenal disease. In most cases, adrenal …

Adrenocortical carcinoma (ACC) is a rare and in most cases steroid hormone-producing
tumor with variable prognosis. The purpose of these guidelines is to provide clinicians with …

Background Adrenocortical carcinoma is a rare, aggressive cancer for which few treatment
options are available. Linsitinib (OSI-906) is a potent, oral small molecule inhibitor of both …

Background: Recurrence of adrenocortical carcinoma (ACC) even after complete (R0)
resection occurs frequently. Objective: The aim of this study was to identify markers with …

Adrenocortical carcinoma (ACC) is a rare malignancy that harbors a dismal prognosis in
advanced stages. Mitotane is approved as an orphan drug for treatment of ACC and …